India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Tampa Bay’s real estate market is entering a rare sweet spot in 2026—balancing rising inventory, steady demand, and booming commercial development. With housing supply up to 4.3 months and prices stabilizing, the region is shifting from frenzy to sustainable growth. Population migration, modernized commercial spaces, and lifestyle-focused districts like Water Street and Midtown continue to fuel Tampa’s evolution. But even amid luxury expansion, affordability remains the top challenge shaping the next phase of opportunity for real estate professionals.
Each year, AZ Big Media spotlights the visionaries shaping Arizona’s fast‑growing commercial real estate landscape. The 2026 AZ Big 100 list highlights 50 influential builders, developers, architects, and innovators who are driving sustainable growth, expanding infrastructure, and redefining community-focused design. For professionals in real estate, construction, finance, and related fields, this roundup offers a powerful look at the leadership and trends guiding Arizona’s next era of development.
After years of relentless premium increases, State Farm has filed for a 10% homeowners insurance rate reduction in Florida, signaling that recent legislative reforms may finally be stabilizing the state’s turbulent insurance market. This move could pressure other insurers to follow and marks one of the first meaningful signs of relief for Florida homeowners and real estate professionals.
Illinois has updated its insurance supplier diversity reporting requirements, impacting insurers, HMOs, dental plan corporations, and accredited reinsurers with at least $50 million in admitted assets. Beginning April 1, 2026, companies must use the state’s new PDF template and file through SERFF, following strict formatting rules for procurement, certification types, and diversity goals. The update signals a stronger statewide push for transparency and equitable contracting, making accurate compliance essential for insurance and finance professionals.
YouTube superstar MrBeast has officially moved into the world of finance with his acquisition of Step, a fast‑growing youth money management app backed by Stripe and major venture investors. Now operating under Beast Industries, Step is poised to bring modern financial tools—like credit building, investing, and budgeting—to millions of teens and young adults. With MrBeast’s massive reach and Step’s existing user base of over 7 million, this move could reshape how the next generation learns essential financial skills, giving future professionals a stronger foundation whether they pursue real estate, mortgage, insurance, finance, or any career where smart money decisions matter.
Long Island’s commercial market just hit an all‑time high, closing $4.1 billion in commercial real estate sales across Nassau and Suffolk counties in 2025—a 71 percent jump from the prior year. Specialty-use properties like assisted living and self‑storage led the surge, fueled by lower interest rates and renewed investor confidence.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
